JP2009508902A5 - - Google Patents

Download PDF

Info

Publication number
JP2009508902A5
JP2009508902A5 JP2008531609A JP2008531609A JP2009508902A5 JP 2009508902 A5 JP2009508902 A5 JP 2009508902A5 JP 2008531609 A JP2008531609 A JP 2008531609A JP 2008531609 A JP2008531609 A JP 2008531609A JP 2009508902 A5 JP2009508902 A5 JP 2009508902A5
Authority
JP
Japan
Prior art keywords
formula
alkyl
compound
iif
iie
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008531609A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009508902A (ja
Filing date
Publication date
Priority claimed from EP05020508A external-priority patent/EP1764095A1/en
Application filed filed Critical
Publication of JP2009508902A publication Critical patent/JP2009508902A/ja
Publication of JP2009508902A5 publication Critical patent/JP2009508902A5/ja
Pending legal-status Critical Current

Links

JP2008531609A 2005-09-20 2006-09-20 セレクチンリガンド活性を有する新規なニトロカテコール誘導体 Pending JP2009508902A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05020508A EP1764095A1 (en) 2005-09-20 2005-09-20 Novel nitrocatechol derivatives having selectin ligand activity
PCT/EP2006/009155 WO2007039114A1 (en) 2005-09-20 2006-09-20 Novel nitrocatechol derivatives having selectin ligand activity

Publications (2)

Publication Number Publication Date
JP2009508902A JP2009508902A (ja) 2009-03-05
JP2009508902A5 true JP2009508902A5 (https=) 2009-11-12

Family

ID=35892515

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008531609A Pending JP2009508902A (ja) 2005-09-20 2006-09-20 セレクチンリガンド活性を有する新規なニトロカテコール誘導体

Country Status (10)

Country Link
US (2) US7851501B2 (https=)
EP (2) EP1764095A1 (https=)
JP (1) JP2009508902A (https=)
CN (2) CN101374508B (https=)
AU (1) AU2006299184B8 (https=)
BR (1) BRPI0616391A2 (https=)
CA (1) CA2622935A1 (https=)
IL (1) IL190157A0 (https=)
RU (1) RU2428979C2 (https=)
WO (1) WO2007039114A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6838452B2 (en) * 2000-11-24 2005-01-04 Vascular Biogenics Ltd. Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
EP1577289A1 (en) * 2004-03-18 2005-09-21 Revotar Biopharmaceuticals AG Non-glycosylated/-glycosidic/-peptidic small molecule selectin inhibitors for the treament of inflammatory disorders
EP1764094A1 (en) * 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Novel multi-cyclic compounds and their use
EP1764095A1 (en) * 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Novel nitrocatechol derivatives having selectin ligand activity
EP1764096A1 (en) * 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Novel phloroglucinol derivatives having selectin ligand activity
EP1764093A1 (en) * 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Novel aromatic compounds and their use in medical applications
JP2010504978A (ja) * 2006-09-29 2010-02-18 アイデニクス ファーマシューティカルズ，インコーポレーテッド Ｈｉｖ阻害剤としての鏡像異性的に純粋なホスホインドール
DE102007018151A1 (de) * 2007-04-16 2008-10-23 Günenthal GmbH Neue Vanilloid-Rezeptor Liganden und ihre Verwendung zur Herstellung von Arzneimitteln
CA2684105C (en) 2007-05-03 2011-09-06 Pfizer Limited Pyridine derivatives
MY150032A (en) * 2007-07-19 2013-11-29 Merck Sharp & Dohme Heterocyclic amide compounds as protein kinase inhibitors
TWI529165B (zh) * 2008-08-29 2016-04-11 Suntory Holdings Ltd Novel epigallocatechin gallate 3-mer, and the use of alpha-glucosidase inhibitors containing epigallocatechin gallate polymers
ES2781828T3 (es) * 2008-11-19 2020-09-08 Boehringer Ingelheim Animal Health Usa Inc Composiciones que comprenden un aril pirazol y/o una formamidina, procedimientos y usos de las mismas
US8399519B2 (en) 2008-12-19 2013-03-19 Merz Pharma Gmbh & Co. Kgaa 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases
TWI432188B (zh) * 2008-12-19 2014-04-01 Merz Pharma Gmbh & Co Kgaa 供治療發炎性皮膚疾病之１－胺基－烷基環己烷衍生物類
US8557805B2 (en) * 2008-12-29 2013-10-15 Takeda Pharmaceutical Company Limited Fused ring compound and use thereof
US8366791B1 (en) 2011-09-02 2013-02-05 Warner Babcock Institute Formulation and method for hair dyeing
US8569372B2 (en) * 2011-09-27 2013-10-29 Hsiao-Ming Chao Method for preventing or treating a disease, disorder or condition induced by retina ischemia
US8828100B1 (en) 2013-10-14 2014-09-09 John C. Warner Formulation and processes for hair coloring
CN107405315A (zh) * 2015-01-22 2017-11-28 米托充制药公司 用于治疗神经肌肉、神经变性、自身免疫、发育和/或代谢疾病的脑源性神经营养因子(bdnf)的诱导表达
CA3109798A1 (en) 2018-08-17 2020-02-20 The Trustees Of The University Of Pennsylvania Compositions and methods for treatment of acute lung injury

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4363813A (en) 1979-07-09 1982-12-14 Kureha Kagaku Kogyo Kabushiki Kaisha 2-(3,4,5-Trimethoxyphenyl)-4,5-disubstituted thiazoles
JPS58156932A (ja) * 1982-03-11 1983-09-19 Fuji Photo Film Co Ltd ハロゲン化銀カラ−写真感光材料
US4757084A (en) 1984-02-29 1988-07-12 Merck & Co., Inc. 2,5-diaryl tetrahydrothiophenes and analogs thereof as PAF-antagonists
GB2238047B (en) 1989-11-03 1993-02-10 Orion Yhtymae Oy Stable polymorphic form of (e)-n,n-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide and the process for its preparation
EP0465122A1 (en) 1990-06-29 1992-01-08 Merck & Co. Inc. Process of making 2,5-diaryl tetrahydrofurans and analogs thereof useful as paf antagonists
US5374772A (en) 1992-12-08 1994-12-20 Hoffmann-Laroche Inc. Substituted benzoic acids, inhibitors of phospholipases A2
US5444050A (en) 1994-04-29 1995-08-22 Texas Biotechnology Corporation Binding of E-selectin or P-selectin to sialyl Lewisx or sialyl-Lewisa
UA52607C2 (uk) * 1995-06-29 2003-01-15 Тексіс Байотекнолоджі Корпорейшн Похідні біфенілів, фармацевтична композиція на їх основі та спосіб інгібування (варіанти)
KR19990028543A (ko) 1995-06-29 1999-04-15 한스 루돌프 하우스, 헨리테 브룬너, 베아트리체 귄터 시알릴-루이스 ｘ 및 시알릴-루이스 ａ의 유사체로서의 디글리코실화 1,2-디올
DE19532902A1 (de) * 1995-09-06 1997-03-13 Hoechst Ag Neuartige Glycomimetika als Selektin-Antagonisten und daraus hergestellte entzündungshemmend wirkende Arzneimittel
WO1997031864A1 (en) * 1996-03-01 1997-09-04 Dionex Corporation Anion-exchange resins with at least two different nitrogen containing ion-exchange groups
FR2761066B1 (fr) * 1997-03-24 2000-11-24 Sod Conseils Rech Applic Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
WO1999029706A2 (en) 1997-12-08 1999-06-17 Glycomed Incorporated DISALICYLATE ANALOG BASED SIALYL LEWISx MIMETICS
AU1804299A (en) 1997-12-08 1999-06-28 Glycomed Incorporated Sialyl lewis x and sialyl lewis a glycomimetics
WO2000033836A1 (en) 1998-12-04 2000-06-15 Ontogen Corporation 5-membered heterocycles for the treatment of human diseases involving modulators of selectins
GB2344819A (en) * 1998-12-18 2000-06-21 Portela & Ca Sa 2-Phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones
US6248790B1 (en) 2000-06-29 2001-06-19 Parker Hughes Institute Treatment of inflammation with 2,4,6-trihydroxy-alpha-rho-methoxyphenylacetophenone, or its pharmaceutically acceptable derivatives
US6432957B1 (en) 2001-06-29 2002-08-13 Kowa Co., Ltd. Piperazine derivative
JP4425628B2 (ja) 2001-07-23 2010-03-03 ジョンソン・アンド・ジョンソン・コンシューマー・カンパニーズ・インコーポレイテッド 細胞保護化合物、薬学的処方物および美容用処方物、ならびに方法
JP2003055369A (ja) 2001-08-06 2003-02-26 Univ Nihon 新規なフロログルシノール誘導体、及びこれを用いた組成物、抗アレルギー剤
WO2003075905A1 (es) 2002-03-14 2003-09-18 Bobel 246, S.L. Uso de derivados de fenoles 2,4-disubstituidos como inhibidores de la expresion de l-selectinas y de la isoforma inductible de la sintasa del oxido nitrico
JP4266348B2 (ja) 2002-03-27 2009-05-20 カウンシル オブ サイエンティフィク アンド インダストリアル リサーチ Ｄｄｑの媒介するジヒドロアサロンの二量体化によるネオリグナンの生成
WO2003097658A2 (en) 2002-05-16 2003-11-27 Glycomimetics, Inc. Compounds and methods for inhibiting selectin-mediated function
WO2004018502A1 (en) * 2002-08-09 2004-03-04 Yamanouchi Europe B.V. Compounds binding to p-selectin
WO2004056774A2 (en) * 2002-12-19 2004-07-08 Neurogen Corporation Substituted biphenyl-4-carboxylic acid arylamide analogues as capsaicin receptor modulators
WO2004112837A1 (ja) * 2003-05-23 2004-12-29 Hisamitsu Pharmaceutical Co., Inc. 非ステロイド系消炎鎮痛剤含有外用経皮製剤およびインターロイキン－１α生成抑制剤
EP1481669A1 (en) * 2003-05-30 2004-12-01 Yamanouchi Pharmaceutical Co. Ltd. Use of polyhydroxy phenols and polyphenols for modulating p-selectin activity
EP1763533B1 (en) * 2003-11-19 2008-01-09 GlycoMimetics, Inc. Specific antagonist for both e- and p-selectins
EP1577289A1 (en) * 2004-03-18 2005-09-21 Revotar Biopharmaceuticals AG Non-glycosylated/-glycosidic/-peptidic small molecule selectin inhibitors for the treament of inflammatory disorders
EP1764096A1 (en) * 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Novel phloroglucinol derivatives having selectin ligand activity
EP1764095A1 (en) * 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Novel nitrocatechol derivatives having selectin ligand activity
EP1764093A1 (en) * 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Novel aromatic compounds and their use in medical applications
EP1764094A1 (en) * 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Novel multi-cyclic compounds and their use

Similar Documents

Publication Publication Date Title
JP2009508902A5 (https=)
ES2741439T3 (es) Compuestos aromáticos sustituidos
JP2009084270A5 (https=)
ES2752039T3 (es) Agente terapéutico para la dislipidemia
NL8002370A (nl) Esters van acyl-carnitinen, werkwijzen ter bereiding ervan en farmaceutische preparaten, die dergelijke esters bevatten.
CN102079703B (zh) 一种非甾体抗炎药制备方法及其抗炎镇痛作用
US9296678B2 (en) Injectable formulation for treatment and protection of patients having an Inflammatory Reaction or an Ischemia-reperfusion event
RU2008115464A (ru) Новые производные нитрокатехола, обладающие активностью в качестве лигандов селектина
JP2020529988A5 (https=)
CN109970987A (zh) Mof材料、纳米载药材料、药物组合物及其应用
JP2022503890A (ja) ２－（１－アシルオキシ－ｎ－ペンチル）安息香酸と塩基性アミノ酸またはアミノグアニジンによって形成される塩と、その製造方法及び用途
CN109021058A (zh) 具有肿瘤耐药逆转活性的ocotillol型皂苷元衍生物及其制备方法和用途
JP2014511897A5 (https=)
RU2008115434A (ru) Новые производные флороглюцина, обладающие активностью в отношении лиганда селектина
CN103304500B (zh) 新型抗糖尿病化合物、其制备方法和用途
CN102225913B (zh) 大黄酸衍生物以及它们的治疗用途
CN1475488A (zh) 含氟异黄酮衍生物、制造方法及其用途
JP6952911B2 (ja) ２−（αヒドロキシペンチル）安息香酸の有機アミンエステル誘導体薬物
CN104356038A (zh) 维生素d2与d3的共晶及其制备方法和用途
RU2008115491A (ru) Новые полициклические соединения
JP2013503170A5 (https=)
CN108218814A (zh) 靶向sirt3激动剂及其在aml治疗药物中的应用
CN103483282B (zh) 苯基取代的三唑酰胺类化合物及用途
CN101851218A (zh) 4,5-二取代芳基异硒唑类衍生物及其用途
CN115594686B (zh) 一类millpuline A衍生物及其制备方法和医药用途